235 related articles for article (PubMed ID: 12354933)
1. Expression of proteinases and inhibitors in human breast cancer progression and survival.
Baker EA; Stephenson TJ; Reed MW; Brown NJ
Mol Pathol; 2002 Oct; 55(5):300-4. PubMed ID: 12354933
[TBL] [Abstract][Full Text] [Related]
2. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology.
Baker EA; Leaper DJ
Eur J Cancer; 2003 May; 39(7):981-8. PubMed ID: 12706368
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
6. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.
Cid S; Eiro N; González LO; Beridze N; Vazquez J; Vizoso FJ
Clin Breast Cancer; 2016 Aug; 16(4):e83-91. PubMed ID: 27266802
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis in colorectal cancer.
Garbett EA; Reed MW; Brown NJ
Mol Pathol; 1999 Jun; 52(3):140-5. PubMed ID: 10621835
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis in human breast and colorectal cancer.
Garbett EA; Reed MW; Brown NJ
Br J Cancer; 1999 Sep; 81(2):287-93. PubMed ID: 10496354
[TBL] [Abstract][Full Text] [Related]
9. [The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].
Iwata H; Kobayashi S; Iwase H; Okada Y
Nihon Rinsho; 1995 Jul; 53(7):1805-10. PubMed ID: 7630023
[TBL] [Abstract][Full Text] [Related]
10. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Fu OY; Hou MF; Yang SF; Huang SC; Lee WY
Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326
[TBL] [Abstract][Full Text] [Related]
11. Study of matrix metalloproteinases and their inhibitors in breast cancer.
Vizoso FJ; González LO; Corte MD; Rodríguez JC; Vázquez J; Lamelas ML; Junquera S; Merino AM; García-Muñiz JL
Br J Cancer; 2007 Mar; 96(6):903-11. PubMed ID: 17342087
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
13. [The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma].
Jung SA; Yang SK; Kim JS; Shim KN; Im SA; Myung SJ; Jung HY; Yu CS; Kim JC; Hong WS; Kim JH; Min YI
Korean J Gastroenterol; 2005 Jun; 45(6):401-8. PubMed ID: 15973074
[TBL] [Abstract][Full Text] [Related]
14. [The role of metalloproteinases and their inhibitors in pancreatic cancer].
Łukaszewicz M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340
[TBL] [Abstract][Full Text] [Related]
15. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
16. Proteases and their inhibitors in human brain tumours: a review.
Rooprai HK; McCormick D
Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349
[TBL] [Abstract][Full Text] [Related]
17. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database.
McGowan PM; Duffy MJ
Ann Oncol; 2008 Sep; 19(9):1566-72. PubMed ID: 18503039
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract][Full Text] [Related]
20. Proteolysis in human breast cancer.
Garbett EA; Reed MW; Stephenson TJ; Brown NJ
Mol Pathol; 2000 Apr; 53(2):99-106. PubMed ID: 10889910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
